Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C61564
http://purl.obolibrary.org/obo/NCIT_C61564
|
|---|---|
| Preferred Name | Vinflunine |
| Definitions |
A bi-fluorinated derivative of the semi-synthetic vinca alkaloid vinorelbine with antitubulin, antineoplastic, and antiangiogenic activities. Vinflunine inhibits tubulin assembly without any stablization of assembled microtubules at concentrations comparable to those of other vinca alkaloids such as vincristine, vinblastine and vinorelbine; this effect on microtubule dynamics results in cell cycle arrest in mitosis and apoptosis. Compared to other vinca alkaloids, this agent binds weakly to the vinca-binding site, indicating that vinflunine may exhibit reduced neurotoxicity.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A bi-fluorinated derivative of the semi-synthetic vinca alkaloid vinorelbine with antitubulin, antineoplastic, and antiangiogenic activities. Vinflunine inhibits tubulin assembly without any stablization of assembled microtubules at concentrations comparable to those of other vinca alkaloids such as vincristine, vinblastine and vinorelbine; this effect on microtubule dynamics results in cell cycle arrest in mitosis and apoptosis. Compared to other vinca alkaloids, this agent binds weakly to the vinca-binding site, indicating that vinflunine may exhibit reduced neurotoxicity. |
|---|---|
| prefLabel | Vinflunine
|
| label | Vinflunine
|
| Has_Salt_Form | |
| PDQ_Closed_Trial_Search_ID | 419548
|
| code | C61564
|
| Has_Target | |
| prefixIRI | NCIT:C61564
|
| in_subset |
See more
See less
|
| Display_Name | Vinflunine
|
| Preferred_Name | Vinflunine
|
| FDA_UNII_Code | 5BF646324K
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C45H54F2N4O8
|
| Maps_To | Vinflunine
|
| CAS_Registry | 162652-95-1
|
| NCI_Drug_Dictionary_ID | 419548
|
| Legacy Concept Name | Vinflunine
|
| type | |
| ALT_DEFINITION | A substance being studied in the treatment of bladder cancer, lung cancer, and other types of cancer.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 419548
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0672663
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |